Health Technology · Pharmaceuticals: Major · NSE: MEDICAMEQ · data 2026-10-09

Medicamen Biotech Limited

Health check: Average (4.7/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹300.85

Market cap

₹419 cr

P/E

36.7

P/B

—

ROE

3.9%

ROCE

5.5%

Debt / equity

0.18

Dividend yield

0.32%

1-year return

0.3%

52-week high

₹447.65

52-week low

₹212.4

Operating margin

6.0%

Growth

Revenue (last 12 months)	₹203 cr
Net profit (last 12 months)	₹11 cr
Sales growth, 3 years (yearly)	12.0%
Profit growth, 3 years (yearly)	-13.4%

Chart patterns

Double bottom — breakout (key level ₹273.35)

Similar companies

Infinium Pharmachem Ltd. (INFINIUM) · Albert David Ltd (ALBERTDAVD) · Jenburkt Pharmaceuticals Ltd (JENBURPH) · Ambalal Sarabhai Enterprises Limited (AMBALALSA) · Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open MEDICAMEQ in NSE Scanner →